The burden of hyperkalaemia on hospital healthcare resources
Clinical and Experimental Medicine · 2024
DOI: 10.1007/s10238-024-01452-7 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical and Experimental Medicine, 2024. Verfasst von Hugh Logan Ellis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, King's College Hospital NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Hyperkalemia, Hospital Mortality, Health Resources. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AstraZeneca.
Abstract (Originalsprache)
Hyperkalaemia is associated with prolonged hospital admission and worse mortality. Hyperkalaemia may also necessitate clinical consults, therapies for hyperkalaemia and high-dependency bed utilisation. We evaluated the 'hidden' human and organisational resource utilisation for hyperkalaemia in hospitalised patients. This was a single-centre, observational cohort study (Jan 2017-Dec 2020) at a tertiary-care hospital. The CogStack system (data processing and analytics platform) was used to search unstructured and structured data from individual patient records. Association between potassium and death was modelled using cubic spline regression, adjusted for age, sex, and comorbidities. Cox proportional hazards estimated the hazard of death compared with normokalaemia (3.5-5.0 mmol/l). 129,172 patients had potassium measurements in the emergency department. Incidence of hyperkalaemia was 85.7 per 1000. There were 49,011 emergency admissions. Potassium > 6.5 mmol/L had 3.9-fold worse in-hospital mortality than normokalaemia. Chronic kidney disease was present in 21% with potassium 5-5.5 mmol/L and 54% with potassium > 6.5 mmol/L. For diabetes, it was 20% and 32%, respectively. Of those with potassium > 6.5 mmol/L, 29% had nephrology review, and 13% critical care review; in this group 22% transferred to renal wards and 8% to the critical care unit. Dialysis was used in 39% of those with peak potassium > 6.5 mmol/L. Admission hyperkalaemia and hypokalaemia were independently associated with reduced likelihood of hospital discharge. Hyperkalaemia is associated with greater in-hospital mortality and reduced likelihood of hospital discharge. It necessitated significant utilisation of nephrology and critical care consultations and greater likelihood of patient transfer to renal and critical care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, King's College Hospital NHS Foundation Trust, London, UK.
- Department of Basic and Clinical Neuroscience, School of Neuroscience, King's College London, London, UK.
- Renal Sciences, Department of Inflammation Biology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
- Department of Medicine, King's College Hospital NHS Foundation Trust, London, UK. martin.whyte@nhs.net.
Förderung
- AstraZeneca
Zitieren
APA
Logan Ellis, H., Al-Agil, M., Kelly, P. A., Teo, J., Sharpe, C., & Whyte, M. B. (2024). The burden of hyperkalaemia on hospital healthcare resources. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01452-7
Vancouver
Logan Ellis H, Al-Agil M, Kelly PA, Teo J, Sharpe C, Whyte MB. The burden of hyperkalaemia on hospital healthcare resources. Clinical and Experimental Medicine. 2024. doi:10.1007/s10238-024-01452-7
BibTeX
@article{LoganEllis2024,
author = {Logan Ellis, Hugh and Al-Agil, Mohammad and Kelly, Philip A and Teo, James and Sharpe, Claire and Whyte, Martin B},
title = {The burden of hyperkalaemia on hospital healthcare resources},
journal = {Clinical and Experimental Medicine},
year = {2024},
doi = {10.1007/s10238-024-01452-7}
}
EUVIMED